Bioray Biotech Co., Ltd. (7561) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bioray Biotech Co., Ltd. (7561:TWSE), powered by AI.

Current Price
$18.20
Sector
Healthcare
What is the Bioray Biotech Co., Ltd. stock price forecast?

Bioray Biotech Co., Ltd. is currently trading at $18.20. View real-time AI analysis on Alpha Lenz.

What is Bioray Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for Bioray Biotech Co., Ltd. on Alpha Lenz.

What is Bioray Biotech Co., Ltd.'s P/E ratio?

View Bioray Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.

Bioray Biotech Co., Ltd.

TWSE · 7561
NT$18.20-0.95(-4.96%)
Ask about Bioray Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Bioray Biotech Co., Ltd.'s ROE is 7.4%. Explore profitability and growth together.

Ask for details

Company Overview

Bioray Biotech Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and sale of biological and health supplement products. Founded in 1994 and headquartered in Pingtung, Taiwan, Bioray stands out for its focus on innovative health solutions, including functional probiotics, medicinal fungi, immune cell preparations, and advanced cell testing and storage services. The company’s portfolio supports sectors such as healthcare, drug manufacturing, and biotechnology, with offerings that range from raw material production and probiotic capsules to immune function and cancer precision medicine testing. Its cell storage business is geared toward stem and immune cell preservation, as well as cytokine-based therapies, positioning Bioray Biotech at the intersection of preventive health and personalized medicine. With a market capitalization in the hundreds of millions TWD and a broad float, Bioray serves both institutional and individual clients, contributing to Taiwan’s thriving biotech sector and the global life sciences industry through its emphasis on product quality and scientific innovation.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees76

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$222.72MRevenue
0.00Shares Out
76Employees

Margins

47.56%Gross
29.35%EBITDA
16.97%Operating
18.52%Pre-Tax
14.48%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

5.33%Rev 3Yr
7.34%Rev 5Yr
N/AOp Inc 3Yr
233.94%Op Inc 5Yr
301.04%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

5.97%ROA
7.38%ROE
7.75%ROIC

Financial Health

NT$204.92MCash & Cash Equivalents
NT$-121.35MNet Debt
18.45%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bioray Biotech Co., Ltd. (ticker: 7561) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 76 employees.

The current price is 18.2 with a P/E ratio of -x and P/B of -x.

ROE is 7.38% and operating margin is 16.97%. Annual revenue is $223M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bioray Biotech Co., Ltd. (7561) Stock Forecast 2026 $18.20 — Price, Financials & Analyst Targets | Alpha Lenz